d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] BIBF1120 in patient with glioblastoma and progression after standard therapy /temozolomide and radiotherapy (group 1) or after bevacizumab based secondline therapy (group 2) [Country] DK [Cancer type] 
Glioblastoma
Nordic NECT - Inclusion completed
Cancer type